Human mesenchymal stem cells: A bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues
- 20 December 2012
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 228 (4), 680-687
- https://doi.org/10.1002/jcp.24223
Abstract
The continuous discovery of human mesenchymal stem cells (hMSCs) in different tissues is stirring up a tremendous interest as a cell source for regenerative medicine therapies. Historically, hMSCs have been always considered a sub‐population of mononuclear cells present in the bone marrow (BM). Although BM‐hMSCs are still nowadays considered as the most promising mesenchymal stem cell population to reach the clinics due to their capacity to differentiate into multiple tissues, hMSCs derived from other adult and fetal tissues have also demonstrated to possess similar differentiation capacities. Furthermore, different reports have highlighted a higher recurrence of hMSCs in some of these tissues as compared to BM. This offer a fascinating panorama for cell banking, since the creation of a stem cell factory could be envisioned where hMSCs are stocked and used for ad hoc clinical applications. In this review, we summarize the main findings and state of the art in hMSCs isolation, characterization, and differentiation from alternative tissue sources and we attempt to compare their potency for musculoskeletal regeneration. J. Cell. Physiol. 228: 680–687, 2013.Keywords
This publication has 100 references indexed in Scilit:
- Human Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation PotentialStem Cell Reviews and Reports, 2012
- Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in BoneThe International Journal of Cell Cloning, 2010
- Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?The International Journal of Cell Cloning, 2010
- Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffoldsBiomaterials, 2010
- Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repairBiochemical and Biophysical Research Communications, 2009
- Designing materials to direct stem-cell fateNature, 2009
- Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapiesCell and tissue research, 2008
- Isolation of amniotic stem cell lines with potential for therapyNature Biotechnology, 2007
- Adult human mesenchymal stem cell as a target for neoplastic transformationOncogene, 2004
- Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002